ASMB
Assembly Biosciences IncNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Growth Small Cap
$20.34-10.67%
Close Oct 13, 2026
- Market cap
- $323.26M
- 1 month
- -29.8%
- 3 months
- -23.9%
- 1 year
- -23.3%
- 52-week range
- $20.34$38.50
- Dividend
- No dividends on record
- Next-quarter EPS estimate
- -$0.49Quarter to Sep 30, 2026 · 4 analysts · revenue $7.26M
- Short interest
- 30.8% of float2.8M shares · settled Sep 30, 2026 · +34.7% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $74.84M
- Net income
- -$42K
- Free cash flow
- -$38.57M
- Book value
- $305.65M
- Total debt
- $2.35M
- P/E
- —
- Price / sales
- 4.3×
- Price / book
- 1.1×
- FCF yield
- -11.9%
- Net margin
- -0.1%
EODHD (TTM) · as of Oct 14, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ASMB is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
20 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 5
Largest 13-F holders · Q2 2026
93 filers reported a long position in ASMB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GILEAD SCIENCES, INC. | $136.8M | 5M | +10.5% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $44.1M | 1.6M | +30.7% |
| Paradigm Biocapital Advisors LP | $42.7M | 1.6M | +133.6% |
| Commodore Capital LP | $38.9M | 1.4M | +41.5% |
| RA CAPITAL MANAGEMENT, L.P. | $28M | 1M | Unchanged |
| Jupiter Topco LLC | $23.4M | 849.3K | — |
| BlackRock, Inc. | $21.1M | 766.8K | +278.2% |
| Parkman Healthcare Partners LLC | $19.8M | 721.2K | +75.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.4M | 558.9K | +14% |
| Point72 Asset Management, L.P. | $12.7M | 460.6K | +33.9% |
Get the Full Analysis for ASMB
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.
Similar-size companies in Healthcare
ARCT · Arcturus Therapeutics Holdings IncCV · CapsoVision, Inc. Common StockSCTX · Scribe Therapeutics Inc. Common StockENTA · Enanta Pharmaceuticals IncSMTI · Sanara Medtech IncCGC · Canopy Growth CorpTTRX · Turn Therapeutics Inc. Common StockCTNM · Contineum Therapeutics, Inc. Class A Common Stock